US 10800850
Therapeutic antibodies
granted A61KA61K2039/505A61K47/64
Quick answer
US patent 10800850 (Therapeutic antibodies) held by CytomX Therapeutics, Inc. expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K47/64, A61K47/65, A61K47/6849